Vecuronium - Revision history

Danbot: Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T21:58:19Z

Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T17:25:01Z

Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

2026-03-20T16:43:08Z

Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

@@ Line 35: / Line 35: @@
 *Excretion: Renal
 *Mechanism of Action:  Non-depolarizing neuromuscular blocking agent. Long duration with slow onset. Competes for cholinergic receptors at the motor end-plate. [[Acetylcholinesterase inhibitors]] like those found in organophosphates antagonize this action
 ==See Also==

2019-09-23T23:26:36Z

References

2017-01-05T03:23:43Z

Pediatric Dosing

2017-01-05T03:23:25Z

Adult Dosing

← Older revision		Revision as of 03:23, 5 January 2017
Line 5:		Line 5:

	==Adult Dosing==		==Adult Dosing==
	*Not recommended for RSI		*Not recommended for [[RSI]]
	*0.15mg/kg IV based on ideal body weight, can prime with 0.01mg/kg IV		*0.15mg/kg IV based on ideal body weight, can prime with 0.01mg/kg IV

2017-01-05T03:22:47Z

2016-10-05T05:00:57Z

Pharmacology

← Older revision		Revision as of 05:00, 5 October 2016
Line 34:		Line 34:
	*Metabolism: Hepatic		*Metabolism: Hepatic
	*Excretion: Renal		*Excretion: Renal
	*Mechanism of Action: Non-depolarizing neuromuscular blocking agent. Long duration with slow onset. Competes for cholinergic receptors at the motor end-plate. Acetylcholinesterase inhibitors like those found in organophosphates antagonize this action		*Mechanism of Action: Non-depolarizing neuromuscular blocking agent. Long duration with slow onset. Competes for cholinergic receptors at the motor end-plate. [[Acetylcholinesterase inhibitors]] like those found in organophosphates antagonize this action

	==See Also==		==See Also==

2016-07-20T23:30:14Z

Text replacement - "5 mg" to "5mg"

← Older revision		Revision as of 23:30, 20 July 2016
Line 6:		Line 6:
	==Adult Dosing==		==Adult Dosing==
	*Not recommended for RSI		*Not recommended for RSI
	*0.~~15 mg~~/kg IV based on ideal body weight, can prime with 0.01mg/kg IV		*0.15mg/kg IV based on ideal body weight, can prime with 0.01mg/kg IV

	==Pediatric Dosing==		==Pediatric Dosing==

2016-06-26T19:47:56Z

Text replacement - "==Sources==" to "==References=="

← Older revision		Revision as of 19:47, 26 June 2016
Line 39:		Line 39:
	*[[Critical care quick reference]]		*[[Critical care quick reference]]

	==~~Sources~~==		==References==
	Micromedex		Micromedex

	<references/>		<references/>
	[[Category:Pharmacology]]		[[Category:Pharmacology]]

← Older revision		Revision as of 03:22, 5 January 2017
Line 38:		Line 38:
	==See Also==		==See Also==
	*[[Critical care quick reference]]		*[[Critical care quick reference]]
			*Reversal agent: [[Sugammadex]]

	==References==		==References==